microdose of semaglutide Ozempic 'microdosing' is becoming popular. Is it safe? Microdosing Semaglutide: Weight Loss Plus

In people with obesity and established cardiovascular disease but without diabetes, semaglutide 2.4 mg resulted in 20% reduction in major adverse cardiovascular events [(MACE), death from cardiovascular causes, nonfatal myocardial infarction or nonfatal stroke] compared to placebo (SELECT trial) after a mean follow-up of 39.8 months this is the first trial demonstrating cardiovascular benefit for an obesity pharmacotherapy [110]

( Epub 20100821 )

Oral Treatment Option Semaglutide Rybelsus (oral semaglutide) is FDA-approved

If youve tried Semaglutide but hit a plateauor are looking for maximum fat loss and improved metabolic health Tirzepatide might give you the edge

So, similar to the hormone, these drugs tell the pancreas to release more insulin when blood sugar rises (typically during and after eating)

For this reason, most patients transition to a lower, ongoing maintenance dose after the initial 23 month intensive phase, rather than stopping treatment altogether